Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.33 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.33 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | PAK4 | O96013 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | IGF1R | P08069 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.33 |
| ▸ | PRKACA | P17612 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20999744 | 0.82 | ACHE (0.32) | — | |
| SCHEMBL10521307 | 0.80 | CYP1A2 (0.36) | GAA | |
| SCHEMBL27598312 | 0.77 | RECQL (0.34) | CHRNA7RECQL | |
| SCHEMBL27703870 | 0.75 | ELANE (0.32) | RECQL | |
| SCHEMBL28139788 | 0.75 | LMNA (0.38) | RECQLCARM1PRMT6KDM1ADRD2 | |
| SCHEMBL27858737 | 0.73 | RECQL (0.32) | RECQLTSHR | |
| SCHEMBL28139808 | 0.73 | TDP1 (0.37) | CARM1PRMT6TSHRKMT2ADRD2 | |
| SCHEMBL17636534 | 0.72 | ALDH1A1 (0.33) | — | |
| SCHEMBL23053142 | 0.72 | ALDH1A1 (0.40) | TSHRKMT2A | |
| SCHEMBL19484813 | 0.71 | MAOA (0.35) | FLT3BRD4DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106661735-A | Palladium plating solution and palladium coating obtained using same | 日本高纯度化学株式会社 | 2017-05-10 | — | — | CN | claimed |
| US-6232326-B1 | SUFFICIENT TO REDUCE DOPAMINE LEVELS IN SUBCORTICAL AREAS OF THE BRAIN WITHOUT CAUSING SYMPTOMS OF PARKINSON'S DISEASE; PERMANENT OR LONG-TERM AMELIORATION OF SYMPTOMS | ALPHA RESEARCH GROUP, LLC | 2001-05-15 | — | — | US | claimed |
| CN-119930687-A | Method for synthesizing phosphinopyridone by taking pyridine as raw material | 四川大学 | 2025-05-06 | — | — | CN | disclosed |
| EP-3440155-B1 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | ROHM & HAAS ELECT MATERIALS KOREA LTD (KR) | 2021-02-24 | — | — | EP | disclosed |
| EP-3548494-A1 | PHOTODYNAMIC THERAPEUTIC COMPOUNDS AND PHOTODYNAMIC METHODS OF TREATMENT | Salt and Light Pharmaceuticals Pty. Ltd. (AU) | 2019-10-09 | — | — | EP | disclosed |
| WO-2018102849-A1 | PHOTODYNAMIC THERAPEUTIC COMPOUNDS AND PHOTODYNAMIC METHODS OF TREATMENT | SALT AND LIGHT PHARMACEUTICALS PTY. LTD. (AU) | 2018-06-14 | — | — | WO | disclosed |
| CN-106661735-A | Palladium plating solution and palladium coating obtained using same | 日本高纯度化学株式会社 | 2017-05-10 | — | — | CN | disclosed |
| CN-1249095-C | Catalyst for vinyl compound polymerization and process for producing vinyl polymer | IDEMITSU PETROCHEMICAL CO (JP) | 2006-04-05 | — | — | CN | disclosed |
| CN-1416435-A | Catalyst for vinyl compound polymerization and process for producing vinyl polymer | IDEMITSU PETROCHEMICAL CO (JP) | 2003-05-07 | — | — | CN | disclosed |
| CN-1321111-A | Transition metal catalyst and preparation of polymer of alpha-olefin and vinyl compound | IDEMITSU PETROCHEMICAL CO (JP) | 2001-11-07 | — | — | CN | disclosed |
| US-20010020013-A1 | Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp | GUILFORD PHARMACEUTICALS, INC. | 2001-09-06 | — | — | US | disclosed |
| US-6232326-B1 | SUFFICIENT TO REDUCE DOPAMINE LEVELS IN SUBCORTICAL AREAS OF THE BRAIN WITHOUT CAUSING SYMPTOMS OF PARKINSON'S DISEASE; PERMANENT OR LONG-TERM AMELIORATION OF SYMPTOMS | ALPHA RESEARCH GROUP, LLC | 2001-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010020013-A1 | Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp | PARP3, PARP1, PARP2 | CHEK1 28/4885AURKA 325/4885DAPK3 1253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.